StockData
PMGC Holdings Inc. logo

PMGC Holdings Inc. (ELAB) stock

ELABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/3095% below fair value
$1.48−0.18 (-10.84%)

Close on Nov 17, 2026Market cap $1.32MP/E –Yield –

PMGC cash

Cash and short-term investments held at the end of each period.

PMGC's cash was $13.53M at Sep 30, 2026. For fiscal 2025 it was $5.97M, up 49.9% from the year before. The highest annual figure on record is $5.97M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.97M+49.9%
FY2024Dec 31, 2024$3.98M+19.8%
FY2023Dec 31, 2023$3.33M+188.1%
FY2022Dec 31, 2022$1.15M+180.4%
FY2021Dec 31, 2021$411.86K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$13.53M+59.1%
Q2 FY2026Jun 30, 2026$18.79M+197.9%
Q1 FY2026Mar 31, 2026$15.09M+154.8%
Q4 FY2025Dec 31, 2025$5.97M+49.9%
Q3 FY2025Sep 30, 2025$8.50M+32.4%
Q2 FY2025Jun 30, 2025$6.31M+6205.3%
Q1 FY2025Mar 31, 2025$5.92M+527.4%
Q4 FY2024Dec 31, 2024$3.98M+19.8%
Q3 FY2024Sep 30, 2024$6.43M+1247.5%
Q2 FY2024Jun 30, 2024$100.03K-83.4%
Q1 FY2024Mar 31, 2024$943.80K-9.8%
Q4 FY2023Dec 31, 2023$3.33M+188.1%
Q3 FY2023Sep 30, 2023$476.86K-100.0%
Q2 FY2023Jun 30, 2023$601.27K+46.0%
Q1 FY2023Mar 31, 2023$1.05M–
Q4 FY2022Dec 31, 2022$1.15M–
Q3 FY2022Sep 30, 2022$1.57B–
Q4 FY2021Dec 31, 2021$411.86K–

More PMGC figures

See a number that looks wrong?